Alphamab Oncology's total assets for Q4 2025 were ¥2.10B, a decrease of -11.06% from the previous quarter. HK:9966 total liabilities were ¥386.33M for the fiscal quarter, a -23.34% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.